Form 4: TransMedics Director Edwin Kania Jr. Acquires 2,134 Restricted Stock Units

TransMedics Group, Inc. Director and 10% Owner Edwin M. Kania Jr. has reported the acquisition of 2,134 restricted stock units (RSUs) on May 22, 2025, as part of his compensation.

Summary

• Edwin M. Kania Jr., a Director and 10% Owner of TransMedics Group, Inc. (TMDX), acquired 2,134 shares of common stock in the form of restricted stock units (RSUs).
• The transaction date for this acquisition was May 22, 2025, with a price of $0 per share, which is typical for RSU grants.
• Following this transaction, Mr. Kania directly beneficially owns 260,810 shares of common stock.
• Additionally, Mr. Kania indirectly beneficially owns 46,142 shares through the Kania 2021 GRAT B.
• Each RSU represents a contingent right to receive one share of TransMedics Group, Inc.'s common stock.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as the RSU grant aligns director interests with shareholders, which is generally viewed favorably. However, the transaction size is not significant enough to warrant a strong positive sentiment.

Positives

• The acquisition of restricted stock units by a director aligns management's interests with those of shareholders, as the value of the RSUs is tied to the company's stock performance.
• The grant of RSUs at a $0 price is a common form of equity compensation, indicating ongoing commitment to retaining and incentivizing key personnel.

Future Outlook

This document does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic outlook.

Industry Context

This Form 4 filing details an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide broader industry context or trends.

Related Party Transactions

• The acquisition of restricted stock units by Edwin M. Kania Jr., a Director and 10% Owner, from TransMedics Group, Inc. constitutes a related party transaction.

Stakeholder Impact

• Shareholders: The RSU grant aligns the director's interests with shareholders, potentially encouraging decisions that enhance long-term stock value.
• Employees: No direct impact on general employees is indicated by this filing.

Key Dates

Keywords

TransMedics Group, TMDX, SEC Form 4, Insider Trading, Restricted Stock Units, RSU, Director Compensation, Equity Grant, Beneficial Ownership